arrow
J

Juliano J. Cerci

irccs azienda ospedaliero - universitaria di bologna
H指数:19
被引数:1,299

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

68Ga-PSMA-11 in Staging of Unfavorable Intermediate-and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, IAEA Study

^{68}Ga-PSMA-11在不利于中危和高危前列腺癌分期中减少非治愈性前列腺切除术的指征:一项前瞻性、多中心、IAEA研究

2026-01-012
PRE
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative

放射性核素治疗共识命名法:核医学全球倡议的初步建议

2025-03-270
PRE
68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis

前列腺癌的68ga前列腺特异性膜抗原 (PSMA) 正电子发射断层扫描 (pet): 系统评价和荟萃分析

2021-08-0125
OAAI
Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
2021-07-0237
OAAI
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases
2021-02-226
OAAI
Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study

小儿淋巴瘤需要真全身18F-FDG PET/CT吗?IAEA多中心前瞻性研究

2019-01-2511
OAAI
First brazilian consensus of advanced prostate cancer: recommendations for clinical practice

晚期前列腺癌的第一个巴西共识: 临床实践的建议

2017-06-015
OAAI
Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma

联合PET和骨髓受累的活检证据可改善弥漫性大b细胞淋巴瘤的预后预测

2014-09-1159
OAAI